BioServe appointed Kevin Krenitsky, M.D., as its new CEO. The Beltsville, Md.-based company, which does genomics analysis, said Krenitsky brings a wealth of experience in building and managing global biotechnology operations. Prior to joining BioServe, Krenitsky, 40, was the CEO of Parkway Clinical Laboratories in Bensalem, Pa.
Krenitsky, Kevin, M.D.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.